Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio (2010 - 2026)
Madrigal Pharmaceuticals' (MDGL) quarterly Interest Coverage Ratio came in at 11.86 in Q1 2026, up 50.7% year-on-year from 7.87 in Q1 2025, and down 2323.62% on a QoQ basis from 0.49 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 16 years of Interest Coverage Ratio data on file, last reported at 11.86 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 50.7% year-over-year to 11.86 in Q1 2026; TTM through Mar 2026 was 2.23, a 99.71% increase from a year earlier, with the FY2025 full-year figure at 0.51, up 48.11% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 11.86, down from 0.49 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for MDGL reached as high as 6.65 in Q4 2024 and fell as low as 90.09 in Q2 2022.
- Historically, Interest Coverage Ratio has averaged 30.66 across 5 years, with a median of 29.65 in 2023.
- Across the five-year window, Interest Coverage Ratio jumped 122.54% in 2024 and plunged 107.36% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 50.71 in 2022, then surged by 41.81% to 29.51 in 2023, then soared by 122.54% to 6.65 in 2024, then slumped by 107.36% to 0.49 in 2025, then plunged by 2323.62% to 11.86 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 11.86 in Q1 2026, 0.49 in Q4 2025, and 15.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - | -11.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.86 |
| Dec 31, 2025 | -0.49 |
| Sep 30, 2025 | -15.30 |
| Jun 30, 2025 | -14.46 |
| Mar 31, 2025 | -24.06 |
| Dec 31, 2024 | 6.65 |
| Sep 30, 2024 | -31.61 |
| Jun 30, 2024 | -44.46 |
| Mar 31, 2024 | -39.61 |
| Dec 31, 2023 | -29.51 |
| Sep 30, 2023 | -28.12 |
| Jun 30, 2023 | -29.80 |
| Mar 31, 2023 | -33.53 |
| Dec 31, 2022 | -50.71 |
| Sep 30, 2022 | -53.54 |
| Jun 30, 2022 | -90.09 |
| Dec 31, 2020 | -0.45 |
| Sep 30, 2020 | -3,919.07 |
| Jun 30, 2020 | -25,163.50 |
| Mar 31, 2020 | -883.84 |